Access cutting-edge type 1 diabetes mellitus treatment through this clinical trial at a research site in Miami. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Miami location
Preparing your pre-screening questions…
Access type 1 diabetes mellitus specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related type 1 diabetes mellitus treatment provided free
Check if you qualify for this type 1 diabetes mellitus clinical trial in Miami, FL
No-Cost Study Care
Local to Miami
Convenient for FL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Since its inception, the Diabetes Research Institute (DRI) has made significant contributions to the field of diabetes, pioneering many of the techniques used in diabetes centers around the world. Through several clinical trials, DRI has demonstrated that diabetes can be successfully reversed as a result of islet cell transplant. Over the years the following protocols in islet cell transplantation have been initiated: 2000/0329; 2000/0196; 2004/0205; 2000/024; 2006/0200; 2006/0508; 2006/0210. All of the studies listed above will be source of study subjects for this study. Approximately 30 subjects are expected to be enrolled and followed in this trial. After islet-cell transplantation in the parent studies, each subject receives maintenance immunosuppressive medications. The purpose of this protocol is to collect additional follow-up for safety and efficacy from subjects with graft function after their completion in their parent study. It is expected that most subjects will retain measurable islet function and, in the islet-alone studies, continue to receive immunosuppressive medications at the time of completing their parent study.
Sponsor: Rodolfo Alejandro
Yes, this clinical trial (NCT01999374) has an active research site in Miami, FL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for type 1 diabetes mellitus treatment options in Miami, FL, this clinical trial (NCT01999374) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Miami research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 1 diabetes mellitus specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all type 1 diabetes mellitus clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Miami — not just this study.
Browse Pulmonary Embolism Trials in Miami →